Post-Surgery Recovery Stack
3
2,629
intermediate
May 16, 2026
概述
The Post-Surgery Recovery Stack is a targeted tissue repair protocol engineered to accelerate healing timelines following surgical procedures. This intermediate-level stack combines three peptides with complementary mechanisms that address wound healing, inflammation management, and tissue remodeling simultaneously. BPC-157, administered at 500mcg twice daily, forms the foundation of this recovery protocol. This 15-amino-acid peptide, originally isolated from human gastric juice, has demonstrated remarkable wound-healing properties in numerous preclinical studies. It accelerates angiogenesis, promotes fibroblast migration to wound sites, and upregulates growth factor receptors including VEGF and EGF. The twice-daily dosing maintains consistent tissue-level concentrations throughout the healing process, supporting continuous repair signaling around the clock. TB-500, dosed at 5000mcg twice weekly, provides the structural scaffolding for tissue regeneration. As a synthetic fragment of Thymosin Beta-4, it promotes cellular migration by upregulating actin polymerization, allowing repair cells to reach damaged tissue more efficiently. TB-500 also reduces scar tissue formation by modulating inflammatory cytokines during the proliferative phase of wound healing, resulting in more functional tissue restoration rather than fibrotic repair. GHK-Cu at 200mcg daily rounds out the stack with its powerful tissue-remodeling properties. This copper-binding tripeptide stimulates collagen synthesis, attracts immune cells for debris clearance, and promotes nerve regeneration. Research has shown GHK-Cu activates over 4,000 genes involved in tissue repair and remodeling, making it an exceptionally broad-spectrum healing agent. This stack is ideal for individuals recovering from orthopedic surgeries, cosmetic procedures, or any operation involving significant tissue disruption. It is recommended to begin the protocol 3-5 days post-surgery once initial hemostasis is established. BPC-157 injections are most effective when administered near the surgical site subcutaneously. A typical cycle runs 6-8 weeks, aligning with standard surgical recovery windows. Bloodwork monitoring is recommended but not strictly required at this intermediate level.
给药方案
500 mcg
每剂
5,000 mcg
每剂
200 mcg
每剂
目标与证据
Comments
Sign in to join the discussion
免责声明: 此堆栈由社区提交,仅供研究用途。Peptide Contacts不对提交的堆栈的安全性或有效性进行验证。使用任何肽类协议前,请务必咨询合格的医疗专业人员。